{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:47Z","timestamp":1790959187512,"version":"4.1.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s43440-020-00179-y","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:13:45Z","timestamp":1604362425000},"page":"17-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison"],"prefix":"10.1007","volume":"73","author":[{"given":"Tamhida","family":"Masi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-5452","authenticated-orcid":false,"given":"Bhoomika M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"179_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"179_CR2","first-page":"74","volume":"108","author":"MP Okoshi","year":"2017","unstructured":"Okoshi MP, Capalbo RV, Romeiro FG, Okoshi K. Cardiac cachexia: perspectives for prevention and treatment. Arq Bras Cardiol. 2017;108:74\u201380.","journal-title":"Arq Bras Cardiol"},{"key":"179_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000227129","volume":"49","author":"JH Von Roenn","year":"1992","unstructured":"Von Roenn JH, Roth EL, Craig R. HIV-related cachexia: potential mechanisms and treatment. Oncology. 1992;49:50\u20134.","journal-title":"Oncology"},{"key":"179_CR4","doi-asserted-by":"publisher","first-page":"e54564","DOI":"10.1371\/journal.pone.0054564","volume":"8","author":"SW Chang","year":"2013","unstructured":"Chang SW, Pan WS, Beltran DL, Baldelomar LO, Solano MA, Tuero I, et al. Gut hormones, appetite suppression and cachexia in patients with pulmonary TB. PLoS ONE. 2013;8:e54564.","journal-title":"PLoS ONE"},{"key":"179_CR5","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1152\/japplphysiol.00790.2012","volume":"114","author":"AH Remels","year":"2013","unstructured":"Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol. 2013;114:1253\u201362.","journal-title":"J Appl Physiol"},{"key":"179_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12904-019-0429-2","volume":"18","author":"OM Vagnildhaug","year":"2019","unstructured":"Vagnildhaug OM, Brunelli C, Hjermstad MJ, Strasser F, Baracos V, Wilcock A, et al. A prospective study examining cachexia predictors in patients with incurable cancer. BMC Palliat Care. 2019;18:46.","journal-title":"BMC Palliat Care"},{"key":"179_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/1759-7714.12910","volume":"10","author":"R Zhu","year":"2019","unstructured":"Zhu R, Liu Z, Jiao R, Zhang C, Yu Q, Han S, et al. Updates on the pathogenesis of advanced lung cancer-induced cachexia. Thorac Cancer. 2019;10:8\u201316.","journal-title":"Thorac Cancer"},{"key":"179_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14:754\u201362.","journal-title":"Nat Rev Cancer"},{"key":"179_CR9","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KC. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.","journal-title":"Nat Rev Dis Primers"},{"key":"179_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1634\/theoncologist.2018-0266","volume":"24","author":"AE Hendifar","year":"2019","unstructured":"Hendifar AE, Petzel MQ, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, et al. Pancreas cancer-associated weight loss. Oncologist. 2019;24:691\u2013701.","journal-title":"Oncologist"},{"key":"179_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/2013\/642848","volume":"2013","author":"BM Patel","year":"2013","unstructured":"Patel BM, Damle D. Combination of telmisartan with cisplatin controls oral cancer cachexia in rats. BioMed Res Int. 2013;2013:10 (Article ID 642848).","journal-title":"BioMed Res Int"},{"key":"179_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.lfs.2016.04.029","volume":"154","author":"S Sukumaran","year":"2016","unstructured":"Sukumaran S, Patel HJ, Patel BM. Evaluation of role of telmisartan in combination with 5-fluorouracil in gastric cancer cachexia. Life Sci. 2016;154:15\u201323.","journal-title":"Life Sci"},{"key":"179_CR13","volume-title":"Holland-Frei cancer medicine","author":"T Ohnuma","year":"2003","unstructured":"Ohnuma T, et al. Manifestations of Cachexia. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-Frei cancer medicine. 6th ed. Hamilton: BC Decker; 2003.","edition":"6"},{"key":"179_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3322\/canjclin.52.2.72","volume":"52","author":"A Inui","year":"2002","unstructured":"Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin. 2002;52:72\u201391.","journal-title":"CA Cancer J Clin"},{"key":"179_CR15","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z","volume":"92","author":"R Kurzrock","year":"2001","unstructured":"Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer. 2001;92:1684\u20138.","journal-title":"Cancer"},{"key":"179_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1365-2036.2005.02628.x","volume":"22","author":"J Ockenga","year":"2005","unstructured":"Ockenga J, Valentini L. Review article: anorexia and cachexia in gastrointestinal cancer. Aliment Pharmacol Ther. 2005;22:583\u201394.","journal-title":"Aliment Pharmacol Ther"},{"key":"179_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/SPC.0000000000000017","volume":"7","author":"GL Klein","year":"2013","unstructured":"Klein GL, Petschow B, Shaw A, Weaver E. Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target. Curr Opin Support Palliat care. 2013;7:361.","journal-title":"Curr Opin Support Palliat care"},{"key":"179_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/CMAR.S29297","volume":"4","author":"A Tuca","year":"2012","unstructured":"Tuca A, Guell E, Martinez-Losada E, Codorniu N. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res. 2012;4:159\u201369.","journal-title":"Cancer Manag Res"},{"key":"179_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6604828","volume":"100","author":"DA Deans","year":"2009","unstructured":"Deans DA, Tan BH, Wigmore SJ, Ross JA, De Beaux AC, Paterson-Brown S, et al. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer. 2009;100:63\u20139.","journal-title":"Br J Cancer"},{"key":"179_CR20","doi-asserted-by":"publisher","first-page":"e0162998","DOI":"10.1371\/journal.pone.0162998","volume":"11","author":"G Vicentini","year":"2016","unstructured":"Vicentini G, Fracaro L, de Souza SR, Martins HA, Guarnier FA, Zanoni JN. Experimental cancer cachexia changes neuron numbers and peptide levels in the intestine: partial protective effects after dietary supplementation with L-glutamine. PLoS ONE. 2016;11:e0162998.","journal-title":"PLoS ONE"},{"key":"179_CR21","doi-asserted-by":"publisher","first-page":"43376","DOI":"10.18632\/oncotarget.14758","volume":"8","author":"Z Wei","year":"2017","unstructured":"Wei Z, Tan B, Cao S, Liu S, Tan X, Yao Z, et al. The influence of neoadjuvant chemotherapy on gastric cancer patients\u2019 postoperative infectious complications: what is the negative role played by the intestinal barrier dysfunction? Oncotarget. 2017;8:43376\u201388.","journal-title":"Oncotarget"},{"key":"179_CR22","doi-asserted-by":"publisher","first-page":"e47258","DOI":"10.15252\/embr.201847258","volume":"20","author":"M Rohm","year":"2019","unstructured":"Rohm M, Zeigerer A, Machado J, Herzig S. Energy metabolism in cachexia. EMBO Rep. 2019;20:e47258.","journal-title":"EMBO Rep"},{"key":"179_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/00325481.1990.11704531","volume":"87","author":"S Dreizen","year":"1990","unstructured":"Dreizen S, McCredie KB, Keating MJ, Andersson BS. Nutritional deficiencies in patients receiving cancer chemotherapy. Postgrad Med. 1990;87:163\u201370.","journal-title":"Postgrad Med"},{"key":"179_CR24","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1089\/jpm.2011.0098","volume":"14","author":"E Del Fabbro","year":"2011","unstructured":"Del Fabbro E, Hui D, Dalal S, Dev R, Nooruddin ZI, Bruera E. Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med. 2011;14:1004\u20138.","journal-title":"J Palliat Med"},{"key":"179_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ehf2.12184","volume":"4","author":"A Barkhudaryan","year":"2017","unstructured":"Barkhudaryan A, Scherbakov N, Springer J, Doehner W. Cardiac muscle wasting in individuals with cancer cachexia. ESC Heart Fail. 2017;4:458\u201367.","journal-title":"ESC Heart Fail"},{"key":"179_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1074\/jbc.274.2.787","volume":"274","author":"Y Han","year":"1999","unstructured":"Han Y, Weinman S, Boldogh I, Walker RK, Brasier AR. Tumor necrosis factor alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. J Biol Chem. 1999;274:787\u201394.","journal-title":"J Biol Chem."},{"key":"179_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","volume":"170","author":"H Patel","year":"2017","unstructured":"Patel H, Patel B. TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications. Life Sci. 2017;170:56\u201363.","journal-title":"Life Sci"},{"issue":"14","key":"179_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2174\/1389200220666190816162658","volume":"20","author":"DT Dave","year":"2019","unstructured":"Dave DT, Patel BM. Mitochondrial metabolism in cancer cachexia: novel drug targets. Curr Drug Metab. 2019;20(14):1141\u201353.","journal-title":"Curr Drug Metab"},{"key":"179_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.clnu.2007.03.011","volume":"26","author":"RJ Skipworth","year":"2007","unstructured":"Skipworth RJ, Stewart GD, Dejong CH, Preston T, Fearon KC. Pathophysiology of cancer cachexia: much more than host\u2013tumour interaction? Clin Nutr. 2007;26:667\u201376.","journal-title":"Clin Nutr"},{"key":"179_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/cmi.2017.135","volume":"15","author":"T Yoshimura","year":"2018","unstructured":"Yoshimura T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol. 2018;15:335\u201345.","journal-title":"Cell Mol Immunol"},{"key":"179_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/10409238.2013.857291","volume":"49","author":"MA Egerman","year":"2014","unstructured":"Egerman MA, Glass DJ. Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol. 2014;49:59\u201368.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"179_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4161\/rna.23144","volume":"10","author":"M Fabbri","year":"2013","unstructured":"Fabbri M, Paone A, Calore F, Galli R, Croce CM. A new role for microRNAs, as ligands of toll-like receptors. RNA Biol. 2013;10:169\u201374.","journal-title":"RNA Biol"},{"key":"179_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fnut.2017.00069","volume":"4","author":"R Marinho","year":"2018","unstructured":"Marinho R, Alc\u00e2ntara PS, Ottoch JP, Seelaender M. Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting. Fronti Nutr. 2018;4:69.","journal-title":"Fronti Nutr"},{"key":"179_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tem.2014.03.002","volume":"25","author":"P Arner","year":"2014","unstructured":"Arner P, Langin D. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance. Trends Endocrinol Metab. 2014;25:255\u201362.","journal-title":"Trends Endocrinol Metab"},{"key":"179_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli M, Wagner EF. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev. 2016;30:489\u2013501.","journal-title":"Genes Dev"},{"key":"179_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00003465-200411000-00001","volume":"23","author":"AJ Tijerina","year":"2004","unstructured":"Tijerina AJ. The biochemical basis of metabolism in cancer cachexia. Dimens Crit Care Nurs. 2004;23:237\u201343.","journal-title":"Dimens Crit Care Nurs"},{"key":"179_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1113\/jphysiol.2005.085217","volume":"566","author":"C Habold","year":"2005","unstructured":"Habold C, Foltzer-Jourdainne C, Le Maho Y, Lignot JH, Oudart H. Intestinal gluconeogenesis and glucose transport according to body fuel availability in rats. J Physiol. 2005;566:575\u201386.","journal-title":"J Physiol"},{"key":"179_CR38","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1038\/nutd.2016.55","volume":"7","author":"X Bi","year":"2017","unstructured":"Bi X, Henry CJ. Plasma-free amino acid profiles are predictors of cancer and diabetes development. Nutr Diabetes. 2017;7:e249.","journal-title":"Nutr Diabetes"},{"key":"179_CR39","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1248\/yakushi.15-00262-1","volume":"136","author":"M Ohsawa","year":"2016","unstructured":"Ohsawa M, Murakami T, Kume K. Possible involvement of insulin resistance in the progression of cancer cachexia in mice. Yakugaku Zasshi. 2016;136:687\u201392.","journal-title":"Yakugaku Zasshi"},{"key":"179_CR40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fonc.2019.00218","volume":"9","author":"P Schwartsburd","year":"2019","unstructured":"Schwartsburd P. Cancer-induced reprogramming of host glucose metabolism: \u201cVicious Cycle\u201d supporting cancer progression. Front Oncol. 2019;9:218.","journal-title":"Front Oncol"},{"key":"179_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1590\/S0041-87812000000500005","volume":"55","author":"RN Younes","year":"2000","unstructured":"Younes RN, Noguchi Y. Pathophysiology of cancer cachexia. Rev Hosp Cl\u00edn Fac Med Sao Paulo. 2000;55:181\u201393.","journal-title":"Rev Hosp Cl\u00edn Fac Med Sao Paulo"},{"key":"179_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MCO.0b013e32833a5577","volume":"13","author":"A Annibaldi","year":"2010","unstructured":"Annibaldi A, Widmann C. Glucose metabolism in cancer cells. Curr Opin Clin Nutr Metab Care. 2010;13:466\u201370.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"179_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jons.2017.06.002","volume":"3","author":"A Fadaka","year":"2017","unstructured":"Fadaka A, Ajiboye B, Ojo O, Adewale O, Olayide I, Emuowhochere R. Biology of glucose metabolization in cancer cells. J Oncol Sci. 2017;3:45\u201351.","journal-title":"J Oncol Sci"},{"key":"179_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","volume":"3","author":"MA Honors","year":"2012","unstructured":"Honors MA, Kinzig KP. The role of insulin resistance in the development of muscle wasting during cancer cachexia. J Cachexia Sarcopenia Muscle. 2012;3:5\u201311.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"179_CR45","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1242\/dmm.007724","volume":"4","author":"N Draoui","year":"2011","unstructured":"Draoui N, Feron O. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments. Dis Models Mech. 2011;4:727\u201332.","journal-title":"Dis Models Mech"},{"key":"179_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbcan.2019.05.006","volume":"1872","author":"G Grasmann","year":"2019","unstructured":"Grasmann G, Smolle E, Olschewski H, Leithner K. Gluconeogenesis in cancer cells\u2013repurposing of a starvation-induced metabolic pathway? Biochim Biophys Acta Rev Cancer. 2019;1872:24\u201336.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"179_CR47","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1038\/ncomms3508","volume":"4","author":"R Ma","year":"2013","unstructured":"Ma R, Zhang W, Tang K, Zhang H, Zhang Y, Li D, et al. Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma. Nat Commun. 2013;4:2508.","journal-title":"Nat Commun"},{"key":"179_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2617-1619.2018.tb00003.x","volume":"1","author":"LR Viana","year":"2018","unstructured":"Viana LR, Luiz AC, Favero-Santos BC, Salgado CD, Gomes-Marcondes MC. Leucine-rich diet minimises liver glycogen mobilisation and modulates liver gluconeogenesis enzyme expression in tumour-bearing cachectic rats. JCSM Rapid Commun. 2018;1:1\u20139.","journal-title":"JCSM Rapid Commun"},{"key":"179_CR49","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/1097-0142(19820915)50:6<1142::AID-CNCR2820500618>3.0.CO;2-I","volume":"50","author":"K Lundholm","year":"1982","unstructured":"Lundholm K, Edstr\u00f6m S, Karlberg I, Ekman L, Schersten T. Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer. 1982;50:1142\u201350.","journal-title":"Cancer"},{"key":"179_CR50","doi-asserted-by":"publisher","first-page":"65247","DOI":"10.18632\/oncotarget.11247","volume":"7","author":"D Hu","year":"2016","unstructured":"Hu D, Peng F, Lin X, Chen G, Liang B, Li C, et al. The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: the Fujian prospective investigation of cancer (FIESTA) study. Oncotarget. 2016;7:65247\u201356.","journal-title":"Oncotarget"},{"key":"179_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40170-019-0199-6","volume":"7","author":"ED Montal","year":"2019","unstructured":"Montal ED, Bhalla K, Dewi RE, Ruiz CF, Haley JA, Ropell AE, et al. Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer. Cancer Metab. 2019;7:8.","journal-title":"Cancer Metab"},{"key":"179_CR52","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/jcsm.12475","volume":"10","author":"R Tomasin","year":"2019","unstructured":"Tomasin R, Martin AC, Cominetti MR. Metastasis and cachexia: alongside in clinics, but not so in animal models. J Cachexia Sarcopenia Muscle. 2019;10:1183\u201394.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"179_CR53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cell.2016.02.023","volume":"165","author":"D Okin","year":"2016","unstructured":"Okin D, Medzhitov R. The effect of sustained inflammation on hepatic mevalonate pathway results in hyperglycemia. Cell. 2016;165:343\u201356.","journal-title":"Cell"},{"key":"179_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3181\/00379727-199-43336","volume":"199","author":"WG Yasmineh","year":"1992","unstructured":"Yasmineh WG, Theologides A. Effect of tumor necrosis factor on enzymes of gluconeogenesis in the rat. Pro Soc Exp Biol Med. 1992;199:97\u2013103.","journal-title":"Pro Soc Exp Biol Med"},{"key":"179_CR55","first-page":"508409","volume":"2015","author":"L Chen","year":"2015","unstructured":"Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. 2015;2015:508409.","journal-title":"Int J Endocrinol"},{"key":"179_CR56","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O'Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16:553\u201365.","journal-title":"Nat Rev Immunol"},{"key":"179_CR57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fonc.2019.00348","volume":"9","author":"M Neagu","year":"2019","unstructured":"Neagu M, Constantin C, Popescu ID, Zipeto D, Tzanakakis GN, Nikitovic D, et al. Inflammation and metabolism in cancer cell\u2013mitochondria key player. Front Oncol. 2019;9:348.","journal-title":"Front Oncol"},{"key":"179_CR58","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2967\/jnumed.118.216697","volume":"60","author":"RD Dolan","year":"2019","unstructured":"Dolan RD, McLees NG, Irfan A, McSorley ST, Horgan PG, Colville D, et al. The relationship between tumor glucose metabolism and host systemic inflammatory responses in patients with cancer: a systematic review. J Nucl Med. 2019;60:467\u201371.","journal-title":"J Nucl Med"},{"key":"179_CR59","doi-asserted-by":"publisher","first-page":"e0119888","DOI":"10.1371\/journal.pone.0119888","volume":"10","author":"AA Narsale","year":"2015","unstructured":"Narsale AA, Enos RT, Puppa MJ, Chatterjee S, Murphy EA, Fayad R, et al. Liver inflammation and metabolic signaling in ApcMin\/+ mice: the role of cachexia progression. PLoS ONE. 2015;10:e0119888.","journal-title":"PLoS ONE"},{"key":"179_CR60","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12885-018-4271-3","volume":"18","author":"F Wang","year":"2018","unstructured":"Wang F, Liu H, Hu L, Liu Y, Duan Y, Cui R, et al. The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells. BMC Cancer. 2018;18:360.","journal-title":"BMC Cancer"},{"key":"179_CR61","doi-asserted-by":"publisher","first-page":"101042831769596","DOI":"10.1177\/1010428317695960","volume":"39","author":"HA Martins","year":"2017","unstructured":"Martins HA, Bazotte RB, Vicentini GE, Lima MM, Guarnier FA, Hermes-Uliana C, et al. L-Glutamine supplementation promotes an improved energetic balance in Walker-256 tumor\u2013bearing rats. Tumor Biol. 2017;39:1010428317695960.","journal-title":"Tumor Biol"},{"key":"179_CR62","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89:381\u2013410.","journal-title":"Physiol Rev"},{"key":"179_CR63","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/1043-4666(93)90033-2","volume":"5","author":"A Zentella","year":"1993","unstructured":"Zentella A, Manogue K, Cerami A. Cachectin\/TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle. Cytokine. 1993;5:436\u201347.","journal-title":"Cytokine"},{"key":"179_CR64","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fphys.2019.00041","volume":"10","author":"F Penna","year":"2019","unstructured":"Penna F, Ballar\u00f2 R, Beltr\u00e0 M, De Lucia S, Garc\u00eda Castillo L, Costelli P. The skeletal muscle as an active player against cancer cachexia. Front Physiol. 2019;10:41.","journal-title":"Front Physiol"},{"key":"179_CR65","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41591-018-0054-2","volume":"24","author":"G Wang","year":"2018","unstructured":"Wang G, Biswas AK, Ma W, Kandpal M, Coker C, Grandgenett PM, et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat Med. 2018;24:770\u201381.","journal-title":"Nat Med"},{"key":"179_CR66","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12885-016-2121-8","volume":"16","author":"TC Mueller","year":"2016","unstructured":"Mueller TC, Bachmann J, Prokopchuk O, Friess H, Martignoni ME. Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia\u2013can findings from animal models be translated to humans? BMC Cancer. 2016;16:75.","journal-title":"BMC Cancer"},{"key":"179_CR67","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrd4467","volume":"14","author":"S Cohen","year":"2015","unstructured":"Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015;14:58\u201374.","journal-title":"Nat Rev Drug Discov"},{"key":"179_CR68","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fphys.2016.00472","volume":"7","author":"R Barreto","year":"2016","unstructured":"Barreto R, Mandili G, Witzmann FA, Novelli F, Zimmers TA, Bonetto A. Cancer and chemotherapy contribute to muscle loss by activating common signaling pathways. Front Physiol. 2016;7:472.","journal-title":"Front Physiol"},{"key":"179_CR69","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/jcsm.12209","volume":"8","author":"A Loumaye","year":"2017","unstructured":"Loumaye A, de Barsy M, Nachit M, Lause P, van Maanen A, Trefois P, et al. Circulating Activin A predicts survival in cancer patients. J Cachexia Sarcopenia Muscle. 2017;8:768\u201377.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"179_CR70","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajcn\/71.2.583","volume":"71","author":"S Leij-Halfwerk","year":"2000","unstructured":"Leij-Halfwerk S, Dagnelie PC, van den Berg JW, Wattimena JD, Hordijk-Luijk CH, Wilson JP. Weight loss and elevated gluconeogenesis from alanine in lung cancer patients. Am J Clin Nutr. 2000;71:583\u20139.","journal-title":"Am J Clin Nutr"},{"key":"179_CR71","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1042\/cs0980689","volume":"98","author":"HJ Agteresch","year":"2000","unstructured":"Agteresch HJ, Leij-Halfwerk S, Van Den Berg JW, Hordijk-Luijk CH, Wilson JH, Dagnelie PC. Effects of ATP infusion on glucose turnover and gluconeogenesis in patients with advanced non-small-cell lung cancer. Clin Sci. 2000;98:689\u201395.","journal-title":"Clin Sci"},{"key":"179_CR72","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/1097-0142(19820315)49:6<1092::AID-CNCR2820490606>3.0.CO;2-9","volume":"49","author":"ME Burt","year":"1982","unstructured":"Burt ME, Gorschboth CM, Brennan MF. A controlled, prospective, randomized trial evaluating the metabolic effects of enteral and parenteral nutrition in the cancer patient. Cancer. 1982;49:1092\u2013105.","journal-title":"Cancer"},{"key":"179_CR73","first-page":"1968","volume":"39","author":"C Waterhouse","year":"1979","unstructured":"Waterhouse C, Jeanpretre N, Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Can Res. 1979;39:1968\u201372.","journal-title":"Can Res"},{"key":"179_CR74","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.00253.2003","volume":"285","author":"A Barthel","year":"2003","unstructured":"Barthel A, Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab. 2003;285:E685\u201392.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"179_CR75","doi-asserted-by":"publisher","first-page":"a009191","DOI":"10.1101\/cshperspect.a009191","volume":"6","author":"J Boucher","year":"2014","unstructured":"Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6:a009191.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"179_CR76","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13539-011-0043-5","volume":"2","author":"K Trobec","year":"2011","unstructured":"Trobec K, von Haehling S, Anker SD, Lainscak M. Growth hormone, insulin-like growth factor 1, and insulin signaling\u2014a pharmacological target in body wasting and cachexia. J Cachexia Sarcopenia Muscle. 2011;2:191\u2013200.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"179_CR77","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1158\/1078-0432.CCR-16-0495","volume":"22","author":"Y Miyamoto","year":"2016","unstructured":"Miyamoto Y, Hanna DL, Zhang W, Baba H, Lenz HJ. Molecular pathways: cachexia signaling\u2014a targeted approach to cancer treatment. Clin Cancer Res. 2016;22:3999\u20134004.","journal-title":"Clin Cancer Res"},{"key":"179_CR78","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1093\/annonc\/mdx815","volume":"29","author":"R Dev","year":"2018","unstructured":"Dev R, Bruera E, Dalal S. Insulin resistance and body composition in cancer patients. Ann Oncol. 2018;29:ii18\u201326.","journal-title":"Ann Oncol."},{"key":"179_CR79","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.24784","volume":"126","author":"ML Asp","year":"2010","unstructured":"Asp ML, Tian M, Wendel AA, Belury MA. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer. 2010;126:756\u201363.","journal-title":"Int J Cancer"},{"key":"179_CR80","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/jcsm.12360","volume":"10","author":"F Pin","year":"2019","unstructured":"Pin F, Barreto R, Couch ME, Bonetto A, O\u2019Connell TM. Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism. J Cachexia Sarcopenia Muscle. 2019;10:140\u201354.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"179_CR81","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jcsm.12104","volume":"7","author":"EA de Lima Junior","year":"2016","unstructured":"de Lima Junior EA, Yamashita AS, Pimentel GD, De Sousa LG, Santos RV, Gon\u00e7alves CL, et al. Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle. J Cachexia Sarcopenia Muscle. 2016;7:615\u201325.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"179_CR82","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1002\/jcb.29682","volume":"121","author":"F de Fatima Silva","year":"2020","unstructured":"de Fatima Silva F, de Morais H, Ortiz Silva M, da Silva FG, Vianna Croffi R, Serrano-Nascimento C, et al. Akt activation by insulin treatment attenuates cachexia in Walker-256 tumor-bearing rats. J Cell Biochem. 2020;121(11):4558\u201368.","journal-title":"J Cell Biochem."},{"key":"179_CR83","first-page":"1232","volume":"85","author":"J Liu","year":"2000","unstructured":"Liu J, Knezetic JA, Str\u00f6mmer L, Permert J, Larsson J, Adrian TE. The intracellular mechanism of insulin resistance in pancreatic cancer patients. J Clin Endocrinol Metab. 2000;85:1232\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"179_CR84","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.clnu.2012.05.003","volume":"31","author":"A Winter","year":"2012","unstructured":"Winter A, MacAdams J, Chevalier S. Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia. Clin Nutr. 2012;31:765\u201373.","journal-title":"Clin Nutr"},{"key":"179_CR85","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jcp.26811","volume":"234","author":"SI Daas","year":"2019","unstructured":"Daas SI, Rizeq BR, Nasrallah GK. Adipose tissue dysfunction in cancer cachexia. J Cell Physiol. 2019;234:13\u201322.","journal-title":"J Cell Physiol"},{"key":"179_CR86","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/apm.2018.10.01","volume":"8","author":"S Dalal","year":"2019","unstructured":"Dalal S. Lipid metabolism in cancer cachexia. Ann Palliat Med. 2019;8:13\u201323.","journal-title":"Ann Palliat Med"},{"key":"179_CR87","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","volume":"4","author":"SF Schmidt","year":"2018","unstructured":"Schmidt SF, Rohm M, Herzig S, Diaz MB. Cancer cachexia: more than skeletal muscle wasting. Trends Cancer. 2018;4:849\u201360.","journal-title":"Trends Cancer"},{"key":"179_CR88","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","volume":"279","author":"CR Santos","year":"2012","unstructured":"Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012;279:2610\u201323.","journal-title":"FEBS J"},{"key":"179_CR89","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fonc.2020.00298","volume":"10","author":"GP Marceca","year":"2020","unstructured":"Marceca GP, Londhe P, Calore F. Management of cancer cachexia: attempting to develop new pharmacological agents for new effective therapeutic options. Front Oncol. 2020;10:298.","journal-title":"Front Oncol"},{"key":"179_CR90","doi-asserted-by":"publisher","first-page":"17565","DOI":"10.1038\/srep17565","volume":"5","author":"EY Lee","year":"2015","unstructured":"Lee EY, Sakurai K, Zhang X, Toda C, Tanaka T, Jiang M, et al. Unsuppressed lipolysis in adipocytes is linked with enhanced gluconeogenesis and altered bile acid physiology in Insr\/+ P1195L\/+ mice fed high-fat-diet. Sci Rep. 2015;5:17565.","journal-title":"Sci Rep"},{"key":"179_CR91","doi-asserted-by":"publisher","first-page":"154169","DOI":"10.1016\/j.metabol.2020.154169","volume":"105","author":"X Han","year":"2020","unstructured":"Han X, Raun SH, Carlsson M, Sj\u00f8berg KA, Henriquez-Olgu\u00edn C, Ali M, et al. Cancer causes metabolic perturbations associated with reduced insulin-stimulated glucose uptake in peripheral tissues and impaired muscle microvascular perfusion. Metabolism. 2020;105:154169.","journal-title":"Metabolism"},{"key":"179_CR92","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00125-015-3532-9","volume":"58","author":"S Koren","year":"2015","unstructured":"Koren S, DiPilato LM, Emmett MJ, Shearin AL, Chu Q, Monks B, et al. The role of mouse Akt2 in insulin-dependent suppression of adipocyte lipolysis in vivo. Diabetologia. 2015;58:1063\u201370.","journal-title":"Diabetologia"},{"key":"179_CR93","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.trecan.2016.07.005","volume":"2","author":"S Kir","year":"2016","unstructured":"Kir S, Spiegelman BM. Cachexia and brown fat: a burning issue in cancer. Trends Cancer. 2016;2:461\u20133.","journal-title":"Trends Cancer"},{"key":"179_CR94","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","volume":"150","author":"J Wu","year":"2012","unstructured":"Wu J, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150:366\u201376.","journal-title":"Cell"},{"key":"179_CR95","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","volume":"513","author":"S Kir","year":"2014","unstructured":"Kir S, et al. Tumor-derived PTHrP triggers adipose tissue browning and cancer cachexia. Nature. 2014;513:100\u20134.","journal-title":"Nature"},{"key":"179_CR96","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/MCO.0000000000000357","volume":"20","author":"SS Thomas","year":"2017","unstructured":"Thomas SS, Mitch WE. Parathyroid hormone stimulates adipose tissue browning: a pathway to muscle wasting. Curr Opin Clin Nutr Metab Care. 2017;20:153\u20137.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"179_CR97","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fcell.2020.00033","volume":"8","author":"X Sun","year":"2020","unstructured":"Sun X, Feng X, Wu X, Lu Y, Chen K, Ye Y. Fat wasting is damaging: role of adipose tissue in cancer-associated cachexia. Front Cell Dev Biol. 2020;8:33.","journal-title":"Front Cell Dev Biol"},{"key":"179_CR98","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12944-018-0657-0","volume":"17","author":"J Han","year":"2018","unstructured":"Han J, Meng Q, Shen L, Wu G. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Lipids Health Dis. 2018;17:14.","journal-title":"Lipids Health Dis"},{"key":"179_CR99","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.00218.2017","volume":"314","author":"S Winther","year":"2018","unstructured":"Winther S, et al. Restricting glycolysis impairs brown adipocyte glucose and oxygen consumption. Am J Physiol Endocrinol Metab. 2018;314:E214\u201323.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"179_CR100","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1083\/jcb.201403080","volume":"207","author":"JM Olsen","year":"2014","unstructured":"Olsen JM, Sato M, Dallner OS, Sandstr\u00f6m AL, Pisani DF, Chambard JC, et al. Glucose uptake in brown fat cells is dependent on mTOR complex 2\u2013promoted GLUT1 translocation. J Cell Biol. 2014;207:365\u201374.","journal-title":"J Cell Biol"},{"key":"179_CR101","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"VT Samuel","year":"2016","unstructured":"Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126:12\u201322.","journal-title":"J Clin Invest"},{"key":"179_CR102","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrendo.2017.80","volume":"13","author":"MC Petersen","year":"2017","unstructured":"Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol. 2017;13:572\u20138.","journal-title":"Nat Rev Endocrinol"},{"key":"179_CR103","doi-asserted-by":"publisher","first-page":"E743","DOI":"10.1073\/pnas.1714703115","volume":"115","author":"MD Goncalves","year":"2018","unstructured":"Goncalves MD, Hwang SK, Pauli C, Murphy CJ, Cheng Z, Hopkins BD, et al. Fenofibrate prevents skeletal muscle loss in mice with lung cancer. Proc Natl Acad Sci. 2018;115:E743\u201352.","journal-title":"Proc Natl Acad Sci"},{"key":"179_CR104","doi-asserted-by":"publisher","first-page":"e00416","DOI":"10.1042\/BSR20160385","volume":"36","author":"MM Adeva-Andany","year":"2016","unstructured":"Adeva-Andany MM, P\u00e9rez-Felpete N, Fern\u00e1ndez-Fern\u00e1ndez C, Donapetry-Garc\u00eda C, Pazos-Garc\u00eda C. Liver glucose metabolism in humans. Biosci Rep. 2016;36:e00416.","journal-title":"Biosci Rep"},{"key":"179_CR105","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fphar.2016.00521","volume":"7","author":"J Yip","year":"2017","unstructured":"Yip J, Geng X, Shen J, Ding Y. Cerebral gluconeogenesis and diseases. Front Pharmacol. 2017;7:521.","journal-title":"Front Pharmacol"},{"key":"179_CR106","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fmicb.2019.00757","volume":"10","author":"B Siebers","year":"2019","unstructured":"Siebers B, Haferkamp P, Tjaden B, Shen L, Braesen C, Kouril T. The carbon switch at the level of pyruvate and phosphoenolpyruvate in Sulfolobus solfataricus P2. Front Microbiol. 2019;10:757.","journal-title":"Front Microbiol"},{"key":"179_CR107","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3945\/ajcn.2009.27834","volume":"90","author":"MA Veldhorst","year":"2009","unstructured":"Veldhorst MA, Westerterp-Plantenga MS, Westerterp KR. Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet. Am J Clin Nutr. 2009;90:519\u201326.","journal-title":"Am J Clin Nutr"},{"key":"179_CR108","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12976-015-0015-0","volume":"12","author":"DE Friesen","year":"2015","unstructured":"Friesen DE, Baracos VE, Tuszynski JA. Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia. Theo Biol Med Model. 2015;12:17.","journal-title":"Theo Biol Med Model"},{"key":"179_CR109","doi-asserted-by":"publisher","first-page":"820934","DOI":"10.1155\/2015\/820934","volume":"2015","author":"M Ebadi","year":"2015","unstructured":"Ebadi M, Mazurak VC. Potential biomarkers of fat loss as a feature of cancer cachexia. Mediators Inflamm. 2015;2015:820934.","journal-title":"Mediators Inflamm"},{"key":"179_CR110","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.metabol.2016.08.005","volume":"65","author":"T Sato","year":"2016","unstructured":"Sato T, Yoshida Y, Morita A, Mori N, Miura S. Glycerol-3-phosphate dehydrogenase 1 deficiency induces compensatory amino acid metabolism during fasting in mice. Metabolism. 2016;65:1646\u201356.","journal-title":"Metabolism"},{"key":"179_CR111","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","volume":"15","author":"M Foretz","year":"2019","unstructured":"Foretz M, Guigas B, Viollet B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol. 2019;15:569\u201389.","journal-title":"Nat Rev Endocrinol"},{"key":"179_CR112","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1152\/physiolgenomics.00124.2019","volume":"52","author":"AV Khamoui","year":"2020","unstructured":"Khamoui AV, Tokmina-Roszyk D, Rossiter HB, Fields GB, Visavadiya NP. Hepatic proteome analysis reveals altered mitochondrial metabolism and suppressed acyl-CoA synthetase-1 in colon-26 tumor-induced cachexia. Physiol Genom. 2020;52:203\u201316.","journal-title":"Physiol Genom"},{"key":"179_CR113","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.molmed.2013.02.006","volume":"19","author":"SK Das","year":"2013","unstructured":"Das SK, Hoefler G. The role of triglyceride lipases in cancer associated cachexia. Trends Mol Med. 2013;19:292\u2013301.","journal-title":"Trends Mol Med"},{"key":"179_CR114","doi-asserted-by":"publisher","first-page":"8018197","DOI":"10.1155\/2017\/8018197","volume":"2017","author":"JP Hardee","year":"2017","unstructured":"Hardee JP, Montalvo RN, Carson JA. Linking cancer cachexia-induced anabolic resistance to skeletal muscle oxidative metabolism. Oxid Med Cell Longev. 2017;2017:8018197.","journal-title":"Oxid Med Cell Longev"},{"key":"179_CR115","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.3390\/nu7115475","volume":"7","author":"C Saponaro","year":"2015","unstructured":"Saponaro C, Gaggini M, Carli F, Gastaldelli A. The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients. 2015;7:9453\u201374.","journal-title":"Nutrients"},{"key":"179_CR116","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12944-020-01286-8","volume":"19","author":"K Kolczynska","year":"2020","unstructured":"Kolczynska K, Loza-Valdes A, Hawro I, Sumara G. Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review. Lipids Health Dis. 2020;19:113.","journal-title":"Lipids Health Dis"},{"key":"179_CR117","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1002\/jcb.27027","volume":"119","author":"GR Biazi","year":"2018","unstructured":"Biazi GR, Frasson IG, Miksza DR, de Morais H, de Fatima SF, Bertolini GL, et al. Decreased hepatic response to glucagon, adrenergic agonists, and cAMP in glycogenolysis, gluconeogenesis, and glycolysis in tumor-bearing rats. J Cell Biochem. 2018;119:7300\u20139.","journal-title":"J Cell Biochem"},{"key":"179_CR118","doi-asserted-by":"publisher","first-page":"13217","DOI":"10.1073\/pnas.1409638111","volume":"111","author":"Y Lee","year":"2014","unstructured":"Lee Y, Berglund ED, Yu X, Wang MY, Evans MR, Scherer PE, et al. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells. Proc Natl Acad Sci. 2014;111:13217\u201322.","journal-title":"Proc Natl Acad Sci"},{"key":"179_CR119","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mam.2015.09.003","volume":"46","author":"K Sharabi","year":"2015","unstructured":"Sharabi K, Tavares CD, Rines AK, Puigserver P. Molecular pathophysiology of hepatic glucose production. Mol Aspects Med. 2015;46:21\u201333.","journal-title":"Mol Aspects Med"},{"key":"179_CR120","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fendo.2018.00802","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang X, Yang S, Chen J, Su Z. Unraveling the regulation of hepatic gluconeogenesis. Front Endocrinol. 2019;9:802.","journal-title":"Front Endocrinol"},{"key":"179_CR121","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fendo.2019.00535","volume":"10","author":"R Berdeaux","year":"2019","unstructured":"Berdeaux R, Hutchins C. Anabolic and pro-metabolic functions of CREB-CRTC in skeletal muscle: advantages and obstacles for type 2 diabetes and cancer cachexia. Front Endocrinol. 2019;10:535.","journal-title":"Front Endocrinol"},{"key":"179_CR122","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.mce.2010.08.014","volume":"331","author":"M Choudhury","year":"2011","unstructured":"Choudhury M, Qadri I, Rahman SM, Schroeder-Gloeckler J, Janssen RC, Friedman JE. C\/EBP\u03b2 is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells. Mol Cell Endocrinol. 2011;331:102\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"179_CR123","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fphys.2018.00015","volume":"9","author":"Q Du","year":"2018","unstructured":"Du Q, Zhang S, Li A, Mohammad IS, Liu B, Li Y. Astragaloside IV inhibits adipose lipolysis and reduces hepatic glucose production via Akt dependent PDE3B expression in HFD-fed mice. Front Physiol. 2018;9:15.","journal-title":"Front Physiol"},{"key":"179_CR124","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","volume":"100","author":"AJ Grossberg","year":"2010","unstructured":"Grossberg AJ, Scarlett JM, Marks DL. Hypothalamic mechanisms in cachexia. Physiol Behav. 2010;100:478\u201389.","journal-title":"Physiol Behav"},{"key":"179_CR125","first-page":"550","volume":"6","author":"J Bienertov\u00e1-Va\u0161k\u016f","year":"2011","unstructured":"Bienertov\u00e1-Va\u0161k\u016f J, Bienert P, Val\u00edk D, Va\u0161k\u016f A. Melanocortin system in cancer-related cachexia. Cent Eur J Med. 2011;6:550.","journal-title":"Cent Eur J Med"},{"key":"179_CR126","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.nut.2009.07.003","volume":"26","author":"MD DeBoer","year":"2010","unstructured":"DeBoer MD. Update on melanocortin interventions for cachexia: progress toward clinical application. Nutrition. 2010;26:146\u201351.","journal-title":"Nutrition"},{"key":"179_CR127","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.tem.2009.02.002","volume":"20","author":"AS Garfield","year":"2009","unstructured":"Garfield AS, Lam DD, Marston OJ, Przydzial MJ, Heisler LK. Role of central melanocortin pathways in energy homeostasis. Trends Endocrinol Metab. 2009;20:203\u201315.","journal-title":"Trends Endocrinol Metab"},{"key":"179_CR128","doi-asserted-by":"publisher","first-page":"e4774","DOI":"10.1371\/journal.pone.0004774","volume":"4","author":"P Weyermann","year":"2009","unstructured":"Weyermann P, Dallmann R, Magyar J, Anklin C, Hufschmid M, Dubach-Powell J, et al. Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice. PLoS ONE. 2009;4:e4774.","journal-title":"PLoS ONE"},{"key":"179_CR129","doi-asserted-by":"publisher","first-page":"172657","DOI":"10.1016\/j.ejphar.2019.172657","volume":"862","author":"BM Patel","year":"2019","unstructured":"Patel BM, Goyal RK. Liver and insulin resistance: new wine in old bottle!!! Eur J Pharmacol. 2019;862:172657.","journal-title":"Eur J Pharmacol"},{"key":"179_CR130","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12885-016-2424-9","volume":"16","author":"AG Oliveira","year":"2016","unstructured":"Oliveira AG, Gomes-Marcondes MCC. Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats. BMC Cancer. 2016;16:418.","journal-title":"BMC Cancer"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00179-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43440-020-00179-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00179-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T01:28:43Z","timestamp":1612402123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43440-020-00179-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1007\/s43440-020-00179-y","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}